Reception at J.P. Morgan and follow-on research

Summary

In this episode of MedCity FemForward, reporter Marissa Plescia talks with Anna Jeter of AOA Dx. about a pivotal report on the booming potential of women's health sectors. Discover why this already lucrative field isn't just a niche but a smart investment, with 27 unicorns and over $100 billion in exits. Whether you're an entrepreneur or investor, tune in to learn why women's health is not only crucial for societal well-being but also a golden business opportunity..

Episode Highlights

00:10:47 - Misconception of women's health as niche.

00:11:59 - $100 billion in women's health exits.

00:17:26 - 27 unicorns in women's health.

00:31:28 - Diagnostics as a foundational pillar.

00:42:39 - Oncology as a hot spot in women's health.

00:53:11 - Women's health beyond maternal health.

01:15:45 - Response to JP Morgan presentation.

01:41:26 - Women's health as a significant business opportunity.

Episode Resources

• Anna Jeter

• anna.jeter@aoadx.com

• Connect with Marissa Plescia

• mplescia@medcitynews.com

• https://www.linkedin.com/in/marissaplescia/

Keywords

• MedCity FemForward

• women's health

• AOADx

• biotech

• ovarian cancer detection

• diagnostic test

• women's health exits

• investments in women's health

• healthcare sector

• McKinsey report

• trillion dollar opportunity

• merge and acquisition

• IPO

• exit strategy

• unicorns in women's health

• oncology

• breast cancer

• cervical cancer

• screening programs

• capital efficiency

• funding allocation

• PitchBook

• healthcare innovation

• strategic buyers

• investment opportunities